Genmab | SCHULD



Debt Veränderung Datum
Agios Pharmaceuticals USD 48.76M 48.76M 2025-06
Almirall EUR 341.5M 67.31M 2025-03
Amarin USD 0 0 2025-03
Amgen USD 56.2B 1.18B 2025-06
argenx SE 43.15M 4.1M 2025-06
AstraZeneca USD 32.84B 1.19B 2025-06
Bayer EUR 39.39B 1.31B 2025-03
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Demant DKK 15.68B 146M 2024-12
Exelixis USD 179.84M 179.84M 2025-06
Fresenius Medical Care EUR 11.02B 203.55M 2025-06
Galapagos EUR 10.86M 864K 2025-03
Genmab DKK 148M 5M 2025-06
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
GN Store Nord DKK 11.77B 1.46B 2025-03
GRIFOLS EUR 8.82B 1.23B 2025-06
Hikma Pharmaceutical USD 1.31B 30M 2024-12
Insmed USD 564.1M 567.29M 2025-06
Lonza CHF 4.71B 915M 2024-12
Merck EUR 9.4B 704M 2025-06
Novartis USD 31.27B 12M 2025-03
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 22.28B 1.24B 2025-06
UCB EUR 3.03B 12M 2024-12


Genmab SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.